Sort
30,917 grants matching “tumor microenvironment”
Restoring anti-tumor immunity in the microenvironment of head and neck cancer
$309,460Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA
Cell-Specific Transcription in Cancer Microenvironment in vitro and in vivo
$309,460Richard A Steinman · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA
PRECISION METABOLIC THERAPY OF p53 MUTANT TRIPLE NEGATIVE BREAST CANCERS
$309,446Romi Gupta · University Of Alabama At Birmingham · R01 · FY2024 · CA
The identification of human hepatocellular carcinoma metastasis genes
$309,438Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Interpretable deep learning models for translational medicine
$309,404Xinghua Lu · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · LM
Potential of a dominant-negative FGF mutant as a therapeutic in cancer
$309,376Yoshikazu Takada · University Of California At Davis · R01 · FY2012 · CA
Molecular Basis of Slits as Tumor Suppressors Controlling CXCR4/SDF1 in Breast
$309,335Lindsay E Hinck · University Of California Santa Cruz · R01 · FY2009 · CA
Inflammation and Immunosuppression in Lung Cancer
$309,328Cong Yan · Indiana University Indianapolis · R01 · FY2015 · CA
Inflammation and Immunosuppression in Lung Cancer
$309,328Cong Yan · Indiana University Indianapolis · R01 · FY2012 · CA
3D neurovascular unit models
$309,313Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
A phase I trial to assess the safety and immunogenicity of repeated, cluster part
$309,265Ronald D. Alvarez · Johns Hopkins University · P50 · FY2012 · CA
Activation of Intratumoral pDCs by Tumor Self-DNA Coupled with Anti-microbial
$309,259Michel Gilliet · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA
Escape from gammaherpesvirus-induced mRNA destruction
$309,252Britt A Glaunsinger · University Of California Berkeley · R01 · FY2015 · CA
Project 1: Molecular Mechanisms Initiating Prostate Cancer Metastasis
$309,243Leland W. Chung · Cedars-Sinai Medical Center · P01 · FY2018 · CA
Phenotype Interactions in SCLC Development and Detection
$309,191Alissa M Weaver · Vanderbilt University · U01 · FY2022 · CA
To Understand/Augment OX40-mediated Tumor Immunotherapy
$309,177Andrew D Weinberg · Providence Portland Medical Center · R01 · FY2006 · CA
An osteolytic stimuli-responsive nanotherapeutic system for bone metastases
$309,175Xuli Wang · University Of Utah · R01 · FY2017 · CA
An osteolytic stimuli-responsive nanotherapeutic system for bone metastases
$309,175Xuli Wang · University Of Utah · R01 · FY2015 · CA
Targeting Cathepsin L: A Novel Strategy to Impede Prostate and Breast Cancer Meta
$309,175Dietmar W Siemann · University Of Florida · R01 · FY2013 · CA
An osteolytic stimuli-responsive nanotherapeutic system for bone metastases
$309,175Xuli Wang · University Of Utah · R01 · FY2016 · CA
Carbonic anhydrase and pH control in breast cancer cells
$309,175Susan Cooke Frost · University Of Florida · R01 · FY2013 · CA
The Role of CD4+ T Cells in Antitumor Immunity
$309,164Rongfu Wang · Baylor College Of Medicine · R01 · FY2009 · CA
The Role of CD4+ T Cells in Antitumor Immunity
$309,164Rongfu Wang · Baylor College Of Medicine · R01 · FY2010 · CA
Core 2: Ecological Core
$309,149Joel Brown · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2024 · CA
Microenvironment: Imaging/Implications in Brain Tumors
$309,133University Of Pennsylvania · R01 · FY2005 · CA